Skip to main content
Log in

Relevance of animal models for clinical treatment

  • New Approaches—Antimicrobial Agents
  • Review
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The use of animal models has become an integral part of the evaluation of drugs for antimicrobial chemotherapy. Animal models can be used to define the penetration of antimicrobial agents at foci of infections, the time course of in vivo antimicrobial therapy, dose-response relationships, and the influence of therapy on the pathophysiologic consequences of infection. Animal models have been useful in the delineation of many of the basic principles currently used in clinical practice and in the selection of new agents and new therapeutic approaches for clinical trials in humans. In spite of the many positive aspects of animal models, several problems, such as altered pharmacokinetics in animals, can preclude direct application of results to clinical practice. Studies in animal models cannot replace the need for human clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zak O, Sande MA: Correlation of in vitro antimicrobial activity of antibiotics with results of treatment in experimental animal models and human infection. In: Sabath LD (ed): Action of antibiotics in patients. Hans Huber Publishers, Bern, 1982, p. 55–67.

    Google Scholar 

  2. Vogelman B, Gudmundsson S, Turnidge J, Leggett J, Craig WA: In vivo postantibiotic effect in a thigh infection in neutropenic mice. Journal of Infectious Diseases 1988, 157: 287–298.

    CAS  PubMed  Google Scholar 

  3. Roosendaal R, Bakker-Woudenberg IAJM, van den Berg JC, Michel MF: Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimentalKlebsiella pneumoniae pneumonia in rats. Journal of Infectious Diseases 1985, 152: 373–383.

    CAS  PubMed  Google Scholar 

  4. Cars O: Pharmacokinetics of antibiotics in tissues and tissue fluids: a review. Scandinavian Journal of Infectious Diseases 1991, Supplement 74: 23–33.

  5. Van Etta LL, Kravitz GR, Russ TE, Fasching CE, Gerding DN, Peterson LR: Effect of method of administration on extravascular penetration of four antibiotics. Antimicrobial Agents and Chemotherapy 1982, 21: 873–880.

    PubMed  Google Scholar 

  6. Gerding DN, Peterson LR, Hughes CE, Bamberger DM, larson TA: Extravascular antimicrobial distribution and the respective blood concentrations in humans. In: Lorian V (ed): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore, 1991, p. 403–431.

    Google Scholar 

  7. Tauber MG, Sande MA: Pharmacodynamics of antibiotics in experimental bacterial meningitis-two sides to rapid bacterial killing in the cerebrospinal fluid. Scandinavian. Journal of Infectious Diseases 1991, Supplement 74: 173–178.

    Google Scholar 

  8. Carbon C: Impact of the antibiotic dosage schedule on efficacy in experimental endocarditis. Scandinavian Journal of Infectious Diseases 1991, Supplement 74: 163–172.

  9. Norden CW: Lessons learned from animal models of osteomyelitis. Reviews of Infectious Diseases 1988, 10: 103–110.

    CAS  PubMed  Google Scholar 

  10. Wilson WR, Thompson RL, Wilkowski CJ, Washington JA, Guiliani ER, Geraci JE: Short-term therapy for streptococcal infective endocarditis: combined intramuscular administration of penicillin and streptomycin. Journal of the American Medical Association 1981, 254: 360–363.

    Google Scholar 

  11. Hilf M, Yu V, Sharp J, Zuravleff JJ, Korvick JA, Muder RR: Antibiotic therapy forPseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. American Journal of Medicine 1989, 87: 540–546.

    CAS  PubMed  Google Scholar 

  12. Tuomanen E, Durack DT, Tomasz A: Antibiotic tolerance among clinical isolates of bacteria. Antimicrobial Agents and Chemotherapy 1986, 30: 521–527.

    CAS  PubMed  Google Scholar 

  13. Mordenti J: Forecasting cephalosporin and monobactam antibiotic half-lifes in humans from data collected on laboratory animals. Antimicrobial Agents and Chemotherapy 1985, 27: 887–891.

    CAS  PubMed  Google Scholar 

  14. Gerber AU, Brugger HP, Feller C, Stritzko T, Stalder B: Antibiotic therapy of infections due toPseudomonas aeruginosa in normal and granulocytopenic mice: comparison of murine and human pharmacokinetics. Journal of Infectious Diseases 1986, 153: 90–97.

    CAS  PubMed  Google Scholar 

  15. Craig WA, Redington J, Ebert SC: Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. Journal of Antimicrobial Chemotherapy 1991, 27, Supplement C: 29–40.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Craig, W. Relevance of animal models for clinical treatment. Eur. J. Clin. Microbiol. Infect. Dis. 12 (Suppl 1), S55–S57 (1993). https://doi.org/10.1007/BF02389879

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02389879

Keywords

Navigation